Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-441-5 | CAS number: 83121-18-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 August 1984 to 20 September 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 12 May 1981
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- GLP statement dates to Dec 18, 1987
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The test was performed before the OECD guideline 429 (LLNA) entered into force. The Guinea Pig Maximization Test (GPMT) has been carried out as an animal test to predict human sensitization for over a decade and is recommended by international test guidelines such as OECD.
Test material
- Reference substance name:
- 1-(3,5-dichloro-2,4-difluorophenyl)-3-(2,6-difluorobenzoyl)urea
- EC Number:
- 617-441-5
- Cas Number:
- 83121-18-0
- Molecular formula:
- C14 H6 Cl2 F4 N2 O2
- IUPAC Name:
- 1-(3,5-dichloro-2,4-difluorophenyl)-3-(2,6-difluorobenzoyl)urea
- Test material form:
- solid: crystalline
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Kleintierfarm Madoerin AG, CH 4414 Fuellinsdorf / Switzerland
- Age at study initiation: 8-9 weeks
- Weight at study initiation: males: 430 - 507 g, females: 423 - 520 g
- Housing: Individually in Makrolon type-3 cages
- Diet: ad libitum, pelleted standard Kliba 342, guinea pig breeding/maintenance diet
- Water: ad libitum, tap water
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 45-65
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: physiological saline/ polypropylene glycol (1:1)
- Concentration / amount:
- 2.5%
- Day(s)/duration:
- single application
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: physiological saline/polypropylene glycol (1:1)
- Concentration / amount:
- 25%
- Day(s)/duration:
- Day 7/2 days
Challengeopen allclose all
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: physiological saline/polypropylene glycol (1:1)
- Concentration / amount:
- 25%
- Day(s)/duration:
- Day 21/24 h
- No.:
- #2
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: physiological saline/polypropylene glycol (1:1)
- Concentration / amount:
- 25%
- Day(s)/duration:
- Day 28/24 h
- No. of animals per dose:
- 5 males and 5 females for the vehicle control group;
10 males and 10 females for the test substance group. - Details on study design:
- RANGE FINDING TESTS:
The objective of this investigation was to identify irritant test substance concentrations suitable for the induction phase of the main study. In addition, a suitable non-irritant concentration of the test substance, by the topical route of administration, was identified for the Challenge application.
Intradermal injections (0.1 mL/site) were made into the clipped flank of 4 guinea-pigs, using concentrations of 2.5 and 5% of the test substance in physiological saline/polypropylene glycol (1:1). The resulting dermal reactions (erythema and edema) were assessed 24 hours later.
Topical applications: Patches of filter paper (2 x 2 cm) were saturated with concentrations of 25% of the test substance in physiological saline/polypropylene glycol (1:1) and applied to the clipped and shaved flanks of each of 4 guinea-pigs. The patches were covered by a strip of aluminium foil and firmly secured by elastic plaster wrapped around the trunk and covered with impervious adhesive tape. The dressings were removed after an exposure period of 24 hours and the reaction sites were assessed for erythema and edema, on a numerical basis scale (0 to 4 numerical score). Further examination of the sites were performed 24 and 48 hours after removal of the dressings.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: 7 days (intradermal), 2 days (topical)
- Test groups:
Intradermal: single application
Anterior sites: 0.1 mL Freund‘s complete adjuvant 50:50 with physiological saline/polypropylene glycol (1:1) for injection.
Middle sites: 0.1 mL of the test substance, diluted to 2.5% with physiological saline/polypropylene glycol (1:1).
Posterior sites: 0.1 mL of the test substance at the concentration of 2.5%, emulsified in a 50:50 mixture of Freunds’ complete adjuvant, and the vehicle used.
Topical:
One week after the injections, the scapular area was again clipped and shaved free of hair. A 4 x 4 cm patch of filter paper was saturated with the test article (25%) and placed over the injection sites of the test animals. The patch was covered by aluminum foil and firmly secured by an elastic plaster wrapped around the trunk of the animal and secured with impervious adhesive tape. The dressings were left in place for approximately 48 hours.
- Control group: The guinea-pigs of the control group received identical
treatment without the test article.
B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: 21 and 28 (second Challenge was performed one week after the first challenge)
- Exposure period: 24 hours for each challenge
- Test groups: 2 x 2 cm patch of filter paper, saturated with 25% test article in vehicle
- Control group: vehicle only
- Site: left flank
- Evaluation (hr after challenge): just after application, 24 and 48 hours after removal of the patch (for challenge and re-challenge).
OTHER:
Statistics: Mean values with standard deviations where applicable.
Fischer-Test (The Exact Fischer Test for comparison of the basic probability of two binominal distributions, 1971)
INTERPRETATION:
The results evident in test animals at the challenge applications were compared with the results evident in control animals.
An allergic reaction was defined by visible reddening of the challenge site. The significance of difference in the number of animals with positive reactions between the treated group and the control group was assessed by the Fisher Test.
If the dermal reactions of a test animal at challenge were more persistent or marked than those of the control animals, the animal was considered to show evidence of delayed contact hypersensitivity.
If the dermal reactions of a test animal at challenge was not clearly different from the reactions in control group animals, the results for the test animal were considered inconclusive.
If the dermal reactions to the challenge application was identical to or less persistent/marked than the dermal reactions in control animals, the animal was considered to show no evidence of delayed contact hypersensitivity. - Challenge controls:
- The control animals were treated with the test substance in the same concentration as the animals of the test group to avoid wrong positive results (challenge and re-challenge).
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- No data.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Group:
- positive control
- Remarks on result:
- not measured/tested
Any other information on results incl. tables
No mortality was observed.
The body weight gain of the test animals was not affected by the test procedure.
Clinical signs:
Local: Erythema and edema was observed in the control as well as in the test article treated animals after intracutaneous injections.
Systemic: Two control animals and 6 test substance-treated animals showed a decrease in water consumption, slight sedation, ruffled fur, curved body position and enophthalmus at day 4 of the test, whereas at day 5 the same animals showed decrease in water consumption, ruffled fur and slight enophthalmos. They had recovered at day 6 of the test period.
Regarding the dermal reaction to the challenge, there was no significant (p < 0.01) difference between the results of the animals of the test article treated and vehicle control group.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)